High pregnancy rates and reproductive health indicators among female injection-drug users in Vancouver, Canada

European Journal of Contraception and Reproductive Health Care

Volumn 8, Issue 1, 2003, Pages 52-58

  Weber, A E ^a,b,c   Tyndall, M W ^a,b   Spittal, P M ^a   Li, K ^a   Coulter, S ^a   O'Shaughnessy, M V ^a,b   Schechter, M T ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

Human immunodeficiency virus; Injection drug use; Pregnancy; Women

Indexed keywords

COCAINE; DIAMORPHINE;

ABORIGINE; ARTICLE; BIRTH CONTROL; CANADA; CONTRACEPTION; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PREGNANCY RATE; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR;

EID: 0037357095     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/ejc.8.1.52.58     Document Type: Article

References (18)

1. Adams EH, Gfroerer JC, Rouse BA. Epidemiology of substance abuse including alcohol and cigarette smoking. In Prenatal Abuse of Licit and Illicit Drives. Sciences AotNYAo 1989:14-20
2. National Institutes on Drug Abuse. National Survey Shows over 220 000 Women Use Drugs during Pregnancy. Rockville Maryland: Public Information Branch, 1994
3. Gomby DS, Shiono PH. Estimating the number of drug exposed infants. Future Child 1991;1:17-25
4. Bashore RA, Ketchum JS, Staisch KL, et al. Heroin addiction and pregnancy. West J Med 1981;134:506-14
5. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med 1985;313:666-9
6. Chasnoff IJ, Keith L, Schnoll SH, Burns KA. Perinatal aspects of maternal addiction. Curr Probl Obstet Gynecol Fertil 1986;IX:403-40
7. LaFlash S, Aronson RA, Uttech S. Alcohol use during pregnancy: implications for physicians. Wisconsin Med J 1993;92:501-6
8. Hanna EZ, Faden VB, Dufour MC. The effects of substance use during gestation on birth outcome, infant and maternal health. J Subst Abuse 1997;9:111-25
9. Comerford M, Chitwood DD, McElrath K, Taylor J. Pregnancy among women with a history of injection drug use. Drugs Soc 1998;13:177-92
10. Brown LSJ, Mitchell JL, DeVore SL, Primm BJ. Female intravenous drug users and perinatal HIV transmission. N Engl J Med 1989;320:1493-4
11. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997;11:F59-65
12. Tyndall MW, Patrick D, Spittal P, Li K, O'Shaughnessy MV, Schechter MT. Risky sexual behaviours among injection drug users with high HIV prevalence: implications for STD control. Sex Transm Infect 2002;78 (Suppl 1):i170-5
13. Wilson TE, Minkoff H, McCalla S, Petterkin C, Jaccard J. The relationship between pregnancy and sexual risk taking. Am J Obstet Gynecol 1996;174:1033-6
14. Weber AE, Enns C, Hogg RS. Reproductive health indicators in British Columbia: a comparison of Aboriginal and non-Aboriginal women. Can J Public Health 2002;in press
15. Armstrong KA, Regina K, Samost L. Barriers to family planning services among patients in drug treatment programs. Fam Plann Perspect 1991;23:264-71
16. Kline A, Kline E, Oken E. Minority women and sexual choice in the age of AIDS. Soc Sci Med 1992;34:447-57
17. Oliva G, Rienks J, McDermid M. What high-risk women are telling us about access to primary and reproductive health care and HIV prevention services. AIDS Education and Prevention 1999;11:513-24
18. Rosenbaum M. Difficulties in taking care of business: women addicts as mothers. Am J Drug Alcohol Abuse 1979;6:431-46